Tumor necrosis factor alpha as a new target for renal cell carcinoma: two sequential phase II trials of infliximab at standard and high dose.
| Autor: | Harrison ML, Obermueller E, Maisey NR, Hoare S, Edmonds K, Li NF, Chao D, Hall K, Lee C, Timotheadou E, Charles K, Ahern R, King DM, Eisen T, Corringham R, DeWitte M, Balkwill F, Gore M, Harrison, Michelle L, Obermueller, Eva |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 10/10/2007, Vol. 25 Issue 29, p4542-4549, 8p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|